Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,700.00
Ask: 1,779.00
Change: 0.00 (0.00%)
Spread: 79.00 (4.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Coherus, Chesapeake, airline stocks

Wed, 01st Apr 2015 13:20

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index futures pointed to a lower open on Wednesday asa weaker-than-expected report on private sector employmentraised concerns that Friday's impending jobs report could alsopoint to worsening conditions in the labor market. Dow Jonesindustrial average e-mini futures were down 0.16 percentat 17,675, S&P 500 futures were down 0.18 percent at2,057 and Nasdaq 100 futures were down 0.11 percent at4,324.75.

** COHERUS BIOSCIENCES INC, Tuesday close$30.58, -3.04 pct premarket

The biotech company priced its offering of 4.1 millionshares at $29 each, a 5 pct discount to stock's Tuesday close.The upsized $120 million offering represents 12 percent of thecompany's outstanding shares as of Feb. 28.

** CHESAPEAKE ENERGY CORP, Tuesday close$14.16, +2.40 pct premarket

The oil and gas producer's Chairman Dunham Archie bought 1million shares at $13.98 per share on March 27, according to aregulatory filing on Tuesday. The purchase price represents a1.3 percent discount to the stock's Tuesday close. After thepurchase, Archie holds 2.6 million shares of the company.

** AMERICAN AIRLINES GROUP INC, Tuesday close$52.78, -2.08 pct premarket

** DELTA AIR LINES INC, Tuesday close $44.96, -2.29pct premarket

** UNITED CONTINENTAL HOLDINGS INC, Tuesday close$67.25, -2.07 pct premarket

Analysts at Deutsche Bank cut ratings on airlines' stocks to"hold" from "buy", saying they expect disappointing earningsgrowth from international markets. The combination of a strongUS dollar, greater-than-expected capacity increases by non-USairlines, and decelerating global GDP growth are likely tofurther pressure Deutsche Bank's forecast (from internationalmarkets) for 2015, analysts write in a note.

** MACERICH CO, Tuesday close $84.33, -5.02 pctpremarket

** SIMON PROPERTY GROUP INC, Tuesday close $195.64

Simon Property Group scrapped its attempt to buy Macerichafter the smaller shopping mall owner rejected its sweetenedoffer of $23.2 billion including debt. Macerich Chief ExecutiveArthur Coppola said the company's board concluded that the offerdid not reflect the full value of the company.

** GLAXOSMITHKLINE PLC, Tuesday close $46.15, +1.41pct premarket

** MERCK & CO INC, Tuesday close $57.48, -0.23 pctpremarket

Cowen & Co analysts said the drugmaker's vaccine totreat shingles may be more effective than Merck's. Glaxo'svaccine HZ/su should be well positioned to capture market sharefrom Merck's Zostavax if final data from a late-stage studyshows HZ/su has better efficacy while treating older patients,analysts said.

** NUVASIVE INC, Tuesday close $45.99, -5.37 pctpremarket

The medical device maker said Chief Executive Office AlexLukianov resigned after an independent investigation showed hehad not complied with the medical device maker's expensereimbursement and personnel policies. NuVasive has appointedboard member Greg Lucier as interim CEO.

** EVERYWARE GLOBAL INC, Tuesday close $1.2, -76.67pct premarket

The marketer of tabletop and food preparation products saidit expects to file for prepackaged bankruptcy that will give itssecured lenders control of the company after it emerges from thebankruptcy. EveryWare said it expects to file for a prepackagedChapter 11 bankruptcy in the U.S. Bankruptcy Court for theDistrict of Delaware and expects to emerge from bankruptcywithin 60-75 days.

** DYAX CORP, Tuesday close $16.755, +49.33 pctpremarket

The drug developer said its experimental drug, DX-2930, toprevent hereditary angioedema attacks, was found effective in anearly stage study. The drug was also assigned fast-track statusby the U.S. FDA. All seven analysts covering the stock raisedprice targets, saying the strong results show the drug couldeclipse the current standard-of-care preventive treatment forHAE.

** UTI WORLDWIDE INC, Tuesday close $12.3, -14.55pct premarket

The logistics company reported a wider-than-expectedfourth-quarter loss, hurt by lower air and ocean freightforwarding yields and lower volumes in freight forwarding. Thecompany also cuts its 2016 adjusted EBITDA forecast to $125million-$150 million from $190 million-$210 million and saidrevenue would be hurt by the strengthening of the dollar.

** SYNNEX CORP, Tuesday close $77.25, -4.21 pctpremarket

The hardware distributor forecast second-quarter revenue andadjusted profit below analysts' average estimates, sayingrevenue is expected to be lowered by about $130 million due tothe stronger dollar. The company on Tuesday also reportedlower-than-expected first-quarter profit and revenue.

** HEWLETT-PACKARD CO, Tuesday close $31.16, +1.67pct premarket

The computer maker has lodged a claim in London againstMichael Lynch and a former colleague for damages of about $5.1billion over their management of Autonomy, the company it boughtin 2011. Lynch will counter sue, seeking in excess of 100million pounds ($149 million) for loss and damage caused by HP'saccusations, his representatives said in a statement on Tuesday.

($1 = 0.6732 pounds)

** SEARS HOLDINGS CORP, Tuesday close $41.38, +8.72pct premarket

The struggling retailer said it would raise more than $2.5billion by selling stores to a real estate investment trust itis setting up, in the latest move to shore up its finances. Thecompany would set up a REIT, Seritage Growth Properties, whichwill buy and lease back about 254 Sears and Kmart stores. Searswill also form a joint venture with mall operator General GrowthProperties under which it will sell 12 stores to the JVfor a 50 percent stake and $165 million in cash.

** CYREN LTD, Tuesday close $3.03, +4.29 pctpremarket

The Israeli cyber security software maker said it received acontract from a UK-based JV between Mitsubishi Heavy IndustriesLtd and Siemens AG.

** VOLTARI CORP, Tuesday close $1.01, +179.21 pctpremarket

Billionaire investor Carl Icahn raises his stake in thedigital advertising company to 52.3 percent. Icahn bought about4 million Voltari shares at $1.36 each via a rights offering.

** MYLAN NV, Tuesday close $59.35, -1.53 pctpremarket

** ABBOTT LABORATORIES, Tuesday close $46.33

The generic drug maker priced an offering of 35 millionshares at $58.35 per share, a discount of about 2 percent to thestock's Tuesday close. All shares in the offering are to be soldby Abbott Laboratories for net proceeds of about $1.99 billion.

** KINDER MORGAN INC, Tuesday close $42.06, +0.43pct premarket

Canada's Keyera Corp and midstream company KinderMorgan plan to build 4.8 million barrels of new crude oilstorage in the marketing hub of Edmonton, Alberta, the twocompanies said on Tuesday.

** CONSOL ENERGY INC, Tuesday close $27.89, +0.32pct premarket

CNX Coal Resources LP, Consol Energy's thermal coal businessformed as a master limited partnership, filed for an initialpublic offering with U.S. regulators on Wednesday, as Consolshifts focus to boosting natural gas production.

** GENERAL ELECTRIC CO, Tuesday close $24.81, -0.36pct premarket

The U.S. conglomerate will commit to financing a new naturalgas plant in Puerto Rico under a debt restructuring planproposed by creditors of the island's struggling power utility,according to plan documents obtained by Reuters.

** SPRINT CORP, Tuesday close $4.74, +0.84 pctpremarket

A plan to salvage RadioShack Corp's business byco-branding most of its 1,740 surviving stores with cellularphone provider Sprint earned U.S. bankruptcy court approval onTuesday, ending four days of contested court hearings.

** TECK RESOURCES LTD, Tuesday close $13.73, +0.51pct premarket

The mining company on Tuesday poured more coldwater on speculation it was in talks to merge with or acquire arival mining company, saying although it had looked atopportunities none have met its criteria.

** LOCKHEED MARTIN CORP, Tuesday close $202.96

The Pentagon's No. 1 defense equipment supplier said itexpected to complete a contract in the coming months to supplyan undisclosed number of PAC-3 missiles to South Korea,following Monday's announcement by that country's defenseacquisition agency.

** CARPENTER TECHNOLOGY CORP, Tuesday close $38.88

The alloys maker said on Tuesday that it will cut about 10percent of its salaried workforce, or 200 jobs, to reduce costsamid weak oil and gas prices. The company will also cut about 60outsourced positions.

** CAMBREX CORP, Tuesday close $39.63

Craig-Hallum Capital Group LLC started coverage of the drugingredient manufacturer with a "buy" rating and price target of$50. Analysts say Cambrex is one of the top 10 contractmanufacturers of small molecule active drug ingredients, amarket they value at over $50 billion with mid-single digitvolume growth. They also expect the company's earnings per shareto double by 2017.

** OFG BANCORP, Tuesday close $16.32

Guggenheim cut its rating on the Puerto Rico-based lender'sstock to "neutral" from "buy".

** CYRUSONE INC, Tuesday close $31.12, +0.80 pctpremarket

** CINCINNATI BELL INC, Tuesday close $3.53

The data center REIT's former parent Cincinnati Bell halvedits stake through a follow-on offering. CyrusOne said it wouldissue 12.2 million shares of common stock to buy an equal amountof Cincinnati Bell's operating partnership units. The offeringwill cut Cincinnati Bell's stake to 22 percent if the full shoeis exercised, and increase the common shares outstanding toabout 53 million.

** ECHO GLOBAL LOGISTICS INC, Tuesday close $27.26

BB&T Capital Markets cut its rating on the logisticscompany's stock to "hold" from "buy".

** GODADDY INC

The web hosting company has priced its initial publicoffering at $20 per share, above its previously indicated $17 to$19 per share range, valuing it at around $4.5 billion,including debt, according to underwriting sources. GoDaddy'sshares are expected to start trading on Wednesday and list onthe New York Stock Exchange under the symbol "GDDY." (Compiled by Ramkumar Iyer in Bangalore; Editing by SimonJennings)

More News
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.